<rst>
<header>
	<relations>
			<rel name="elaboration" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="purpose" type="rst"/>
			<rel name="evidence" type="rst"/>
			<rel name="manner" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="sequence" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
			<rel name="joint" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">Tom</segment>
<segment id="2" parent="1002" relname="span">Jefferson</segment>
<segment id="3" parent="2" relname="elaboration">( epidemiologist )</segment>
<segment id="4" parent="1005" relname="span">Tom Jefferson is a British epidemiologist ,</segment>
<segment id="5" parent="4" relname="elaboration">based in Rome , Italy ,</segment>
<segment id="6" parent="1006" relname="span">[ 1 ]</segment>
<segment id="7" parent="6" relname="elaboration">who works for the Cochrane Collaboration .</segment>
<segment id="8" parent="1008" relname="span">Jefferson is an author and editor of the Cochrane Collaboration &apos;s acute respiratory infections group , as well as part of four other Cochrane groups .</segment>
<segment id="9" parent="8" relname="evidence">[ 2 ]</segment>
<segment id="10" parent="1010" relname="span">He is also an advisor to the Italian National Agency for Regional Health Services .</segment>
<segment id="11" parent="10" relname="evidence">[ 2 ]</segment>
<segment id="12" parent="1012" relname="preparation">In 1999</segment>
<segment id="13" parent="1013" relname="span">Jefferson was one of the founding members of the Brighton Collaboration along with Harald Heijbel , Ulrich Heininger , and Elisabeth Loupi .</segment>
<segment id="14" parent="13" relname="evidence">[ 3 ]</segment>
<segment id="15" parent="1016" relname="span">He has worked on Cochrane reviews</segment>
<segment id="16" parent="15" relname="elaboration">examining the effectiveness of the anti-viral oseltamivir and the influenza vaccine .</segment>
<segment id="17" parent="1016" relname="evidence">[ 4 ]</segment>
<segment id="18" parent="1018" relname="preparation">Notable work</segment>
<segment id="19" parent="1019" relname="preparation">In 2009</segment>
<segment id="20" parent="1021" relname="span">Jefferson was hired by the governments of Britain and Australia</segment>
<segment id="21" parent="20" relname="purpose">to update a systematic review of oseltamivir .</segment>
<segment id="22" parent="1021" relname="evidence">[ 4 ]</segment>
<segment id="23" parent="1023" relname="span">Initially he had a great deal of trouble getting results of the original trials .</segment>
<segment id="24" parent="23" relname="evidence">[ 4 ]</segment>
<segment id="25" parent="1025" relname="span">Previous researchers had published trials</segment>
<segment id="26" parent="1027" relname="span">without seeing the underlying data</segment>
<segment id="27" parent="28" relname="attribution">and it appeared</segment>
<segment id="28" parent="1028" relname="span">that some of the published papers used ghost writers .</segment>
<segment id="29" parent="1027" relname="evidence">[ 4 ]</segment>
<segment id="30" parent="1031" relname="circumstance">As the company , Roche ,</segment>
<segment id="31" parent="1031" relname="span">that did the trials refused to provide data for independent analysis ,</segment>
<segment id="32" parent="1032" relname="span">their conclusions in 2009 were that benefits could not be shown .</segment>
<segment id="33" parent="32" relname="evidence">[ 4 ]</segment>
<segment id="34" parent="1019" relname="joint">In 2011 Jefferson &apos;s team was provided 22,000 pages of data from the European Medicines Agency</segment>
<segment id="35" parent="1035" relname="span">and Roche eventually provided 3,000 pages of data .</segment>
<segment id="36" parent="35" relname="evidence">[ 4 ]</segment>
<segment id="37" parent="1038" relname="span">In 2012 , Jefferson was the lead author of another Cochrane review of this data</segment>
<segment id="38" parent="37" relname="elaboration">which concluded</segment>
<segment id="39" parent="1039" relname="span">that oseltamivir did not reduce the number of hospitalizations</segment>
<segment id="40" parent="39" relname="elaboration">caused by influenza .</segment>
<segment id="41" parent="1041" relname="attribution">Jefferson said</segment>
<segment id="42" parent="1042" relname="preparation">that this review also found no evidence</segment>
<segment id="43" parent="1043" relname="span">that oseltamivir stopped complications from the disease .</segment>
<segment id="44" parent="43" relname="evidence">[ 5 ]</segment>
<segment id="45" parent="1045" relname="span">His views about the effectiveness of influenza vaccines and his outspokenness about them are also controversial ;</segment>
<segment id="46" parent="1047" relname="joint">at a 2007 meeting on pandemic preparedness he was shunned by other vaccine researchers</segment>
<segment id="47" parent="1047" relname="joint">and ate alone .</segment>
<segment id="48" parent="1047" relname="evidence">[ 1 ]</segment>
<segment id="49" parent="1050" relname="span">Reviews</segment>
<segment id="50" parent="49" relname="elaboration">led by Jefferson have concluded</segment>
<segment id="51" parent="1052" relname="span">that there is insufficient evidence</segment>
<segment id="52" parent="53" relname="attribution">to show</segment>
<segment id="53" parent="1053" relname="span">that influenza vaccines reduce mortality or infection rates .</segment>
<segment id="54" parent="1052" relname="evidence">[ 6 ]</segment>
<segment id="55" parent="1058" relname="attribution">He has said</segment>
<segment id="56" parent="1058" relname="span">that the studies</segment>
<segment id="57" parent="56" relname="elaboration">claiming large reductions in mortality rates as a result of the influenza vaccine are &quot; rubbish &quot; ,</segment>
<segment id="58" parent="1057" relname="evidence">[ 1 ]</segment>
<segment id="59" parent="1059" relname="span">and that &quot; influenza vaccines are about marketing and not science &quot; .</segment>
<segment id="60" parent="59" relname="evidence">[ 7 ]</segment>
<segment id="61" parent="1062" relname="span">He has called repeatedly for placebo-controlled randomized clinical trials</segment>
<segment id="62" parent="1063" relname="span">to prove the efficacy of flu vaccines , a position</segment>
<segment id="63" parent="62" relname="elaboration">that most in the field hold as unethical .</segment>
<segment id="64" parent="1062" relname="evidence">[ 1 ]</segment>
<segment id="65" parent="1065" relname="span">His views on flu vaccines are opposed by the medical establishment .</segment>
<segment id="66" parent="65" relname="evidence">[ 1 ]</segment>
<segment id="67" parent="1067" relname="span">Publications</segment>
<segment id="68" parent="1068" relname="span">Jefferson , T ;</segment>
<segment id="69" parent="1069" relname="joint">Alderson , P ;</segment>
<segment id="70" parent="1070" relname="span">Wager , E ; Davidoff , F</segment>
<segment id="71" parent="70" relname="evidence">( 5 June 2002 ) .</segment>
<segment id="72" parent="1073" relname="preparation">&quot; Effects of editorial peer review :</segment>
<segment id="73" parent="1074" relname="span">a systematic review &quot; . JAMA . 287</segment>
<segment id="74" parent="73" relname="evidence">( 21 ) :</segment>
<segment id="75" parent="1075" relname="span">2784 – 6 .</segment>
<segment id="76" parent="1076" relname="span">doi : 10.1001/jama.287.21.2784 .</segment>
<segment id="77" parent="76" relname="attribution">PMID 12038911 .</segment>
<segment id="78" parent="1078" relname="span">Jefferson , T ;</segment>
<segment id="79" parent="1079" relname="span">Wager , E ; Davidoff , F</segment>
<segment id="80" parent="79" relname="elaboration">( 5 June 2002 ) .</segment>
<segment id="81" parent="1081" relname="span">&quot;</segment>
<segment id="82" parent="1083" relname="span">Measuring the quality of editorial peer review &quot; . JAMA . 287</segment>
<segment id="83" parent="82" relname="evidence">( 21 ) :</segment>
<segment id="84" parent="1084" relname="span">2786 – 90 .</segment>
<segment id="85" parent="1085" relname="span">doi : 10.1001/jama.287.21.2786 .</segment>
<segment id="86" parent="85" relname="attribution">PMID 12038912 .</segment>
<segment id="87" parent="1087" relname="preparation">Jefferson , T ;</segment>
<segment id="88" parent="1088" relname="preparation">Di Pietrantonj , C ;</segment>
<segment id="89" parent="1089" relname="preparation">Debalini , MG ;</segment>
<segment id="90" parent="1090" relname="preparation">Rivetti , A ;</segment>
<segment id="91" parent="1091" relname="span">Demicheli , V</segment>
<segment id="92" parent="91" relname="elaboration">( July 2009 ) .</segment>
<segment id="93" parent="1093" relname="preparation">&quot;</segment>
<segment id="94" parent="95" relname="preparation">Inactivated influenza vaccines :</segment>
<segment id="95" parent="1094" relname="span">methods , policies , and politics &quot; .</segment>
<segment id="96" parent="1096" relname="span">Journal of Clinical Epidemiology . 62</segment>
<segment id="97" parent="96" relname="elaboration">( 7 ) :</segment>
<segment id="98" parent="1098" relname="span">677 – 86 .</segment>
<segment id="99" parent="1099" relname="span">doi : 10.1016/j . jclinepi.2008.07.001 .</segment>
<segment id="100" parent="99" relname="attribution">PMID 19124222 .</segment>
<segment id="101" parent="1100" relname="joint">Jefferson , T. ; Del Mar , C. ; Dooley , L. ; Ferroni , E. ;</segment>
<segment id="102" parent="1102" relname="preparation">Al-Ansary , L. A ;</segment>
<segment id="103" parent="1102" relname="joint">Bawazeer , G. A ; van Driel , M. L ; Foxlee , R. ;</segment>
<segment id="104" parent="1104" relname="span">Rivetti , A.</segment>
<segment id="105" parent="104" relname="elaboration">( 22 September 2009 ) .</segment>
<segment id="106" parent="1107" relname="span">&quot; Physical interventions</segment>
<segment id="107" parent="106" relname="purpose">to interrupt or reduce the spread of respiratory viruses :</segment>
<segment id="108" parent="1107" relname="elaboration">systematic review &quot; .</segment>
<segment id="109" parent="1110" relname="span">BMJ . 339</segment>
<segment id="110" parent="109" relname="elaboration">( sep21 1 ) :</segment>
<segment id="111" parent="1111" relname="span">b3675 – b3675 .</segment>
<segment id="112" parent="1112" relname="span">doi : 10.1136/bmj . b3675 .</segment>
<segment id="113" parent="112" relname="attribution">PMC 2190272 .</segment>
<segment id="114" parent="1114" relname="span">Chan , An-Wen ; Song , Fujian ;</segment>
<segment id="115" parent="1115" relname="span">Vickers , Andrew ;</segment>
<segment id="116" parent="1116" relname="span">Jefferson , Tom ;</segment>
<segment id="117" parent="1117" relname="span">Dickersin , Kay ;</segment>
<segment id="118" parent="1118" relname="span">Gøtzsche , Peter C ; Krumholz , Harlan M ; Ghersi , Davina ; van der Worp , H Bart</segment>
<segment id="119" parent="118" relname="elaboration">( January 2014 ) .</segment>
<segment id="120" parent="1120" relname="span">&quot; Increasing value and reducing waste :</segment>
<segment id="121" parent="120" relname="elaboration">addressing inaccessible research &quot; .</segment>
<segment id="122" parent="1121" relname="joint">The Lancet .</segment>
<segment id="123" parent="1123" relname="span">383</segment>
<segment id="124" parent="123" relname="elaboration">( 9913 ) :</segment>
<segment id="125" parent="1124" relname="joint">257 – 266 .</segment>
<segment id="126" parent="1126" relname="preparation">doi : 10.1016/S0140-6736(13)62296-5 .</segment>
<segment id="127" parent="1126" relname="joint">PMC 4533904 .</segment>
<segment id="128" parent="1127" relname="joint">PMID 24411650 .</segment>
<segment id="129" parent="1128" relname="joint">Doshi , P. ;</segment>
<segment id="130" parent="1130" relname="span">Jefferson , T.</segment>
<segment id="131" parent="130" relname="elaboration">( 2 March 2015 ) .</segment>
<segment id="132" parent="1131" relname="joint">&quot; The evidence base for new drugs &quot; .</segment>
<segment id="133" parent="1133" relname="span">BMJ . 350</segment>
<segment id="134" parent="1134" relname="span">( mar02 6 ) :</segment>
<segment id="135" parent="134" relname="elaboration">h952 – h952 .</segment>
<segment id="136" parent="1133" relname="elaboration">doi : 10.1136/bmj . h952 .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="span" parent="1003" relname="preparation"/>
<group id="1003" type="multinuc" parent="1001" relname="span"/>
<group id="1004" type="span" parent="1003" relname="joint"/>
<group id="1005" type="span" parent="1004" relname="span"/>
<group id="1006" type="span" parent="1005" relname="evidence"/>
<group id="1008" type="span" parent="1003" relname="joint"/>
<group id="1010" type="span" parent="1003" relname="joint"/>
<group id="1011" type="span" parent="1003" relname="joint"/>
<group id="1012" type="multinuc" parent="1011" relname="span"/>
<group id="1013" type="span" parent="1012" relname="sequence"/>
<group id="1015" type="span" parent="1012" relname="sequence"/>
<group id="1016" type="span" parent="1015" relname="span"/>
<group id="1017" type="span" parent="1012" relname="sequence"/>
<group id="1018" type="span" parent="1017" relname="span"/>
<group id="1019" type="multinuc" parent="1018" relname="span"/>
<group id="1020" type="span" parent="1019" relname="joint"/>
<group id="1021" type="span" parent="1020" relname="span"/>
<group id="1023" type="span" parent="1019" relname="joint"/>
<group id="1025" type="span" parent="1019" relname="joint"/>
<group id="1026" type="span" parent="25" relname="manner"/>
<group id="1027" type="span" parent="1026" relname="span"/>
<group id="1028" type="span" parent="26" relname="elaboration"/>
<group id="1030" type="span" parent="1019" relname="joint"/>
<group id="1031" type="span" parent="1030" relname="span"/>
<group id="1032" type="span" parent="31" relname="elaboration"/>
<group id="1035" type="span" parent="1019" relname="joint"/>
<group id="1037" type="span" parent="1019" relname="joint"/>
<group id="1038" type="span" parent="1039" relname="attribution"/>
<group id="1039" type="span" parent="1037" relname="span"/>
<group id="1040" type="span" parent="1019" relname="joint"/>
<group id="1041" type="span" parent="1040" relname="span"/>
<group id="1042" type="multinuc" parent="1041" relname="span"/>
<group id="1043" type="span" parent="1042" relname="joint"/>
<group id="1045" type="span" parent="1042" relname="joint"/>
<group id="1046" type="span" parent="45" relname="elaboration"/>
<group id="1047" type="multinuc" parent="1046" relname="span"/>
<group id="1049" type="multinuc" parent="1042" relname="joint"/>
<group id="1050" type="span" parent="1049" relname="same_unit"/>
<group id="1051" type="span" parent="1049" relname="same_unit"/>
<group id="1052" type="span" parent="1051" relname="span"/>
<group id="1053" type="span" parent="51" relname="elaboration"/>
<group id="1056" type="span" parent="1042" relname="joint"/>
<group id="1057" type="span" parent="1056" relname="span"/>
<group id="1058" type="span" parent="1057" relname="span"/>
<group id="1059" type="span" parent="1042" relname="joint"/>
<group id="1061" type="span" parent="1042" relname="joint"/>
<group id="1062" type="span" parent="1061" relname="span"/>
<group id="1063" type="span" parent="61" relname="purpose"/>
<group id="1065" type="span" parent="1042" relname="joint"/>
<group id="1066" type="span" parent="1042" relname="joint"/>
<group id="1067" type="span" parent="1066" relname="span"/>
<group id="1068" type="span" parent="67" relname="elaboration"/>
<group id="1069" type="multinuc" parent="68" relname="elaboration"/>
<group id="1070" type="span" parent="1069" relname="joint"/>
<group id="1071" type="multinuc" parent="1067" relname="elaboration"/>
<group id="1072" type="span" parent="1071" relname="joint"/>
<group id="1073" type="multinuc" parent="1072" relname="span"/>
<group id="1074" type="span" parent="1073" relname="same_unit"/>
<group id="1075" type="span" parent="1073" relname="same_unit"/>
<group id="1076" type="span" parent="75" relname="elaboration"/>
<group id="1077" type="multinuc" parent="1071" relname="joint"/>
<group id="1078" type="span" parent="1077" relname="joint"/>
<group id="1079" type="span" parent="78" relname="elaboration"/>
<group id="1080" type="multinuc" parent="1077" relname="joint"/>
<group id="1081" type="span" parent="1080" relname="joint"/>
<group id="1082" type="multinuc" parent="81" relname="elaboration"/>
<group id="1083" type="span" parent="1082" relname="same_unit"/>
<group id="1084" type="span" parent="1082" relname="same_unit"/>
<group id="1085" type="span" parent="84" relname="elaboration"/>
<group id="1086" type="span" parent="1080" relname="joint"/>
<group id="1087" type="span" parent="1086" relname="span"/>
<group id="1088" type="span" parent="1087" relname="span"/>
<group id="1089" type="span" parent="1088" relname="span"/>
<group id="1090" type="multinuc" parent="1089" relname="span"/>
<group id="1091" type="span" parent="1090" relname="joint"/>
<group id="1092" type="span" parent="1090" relname="joint"/>
<group id="1093" type="multinuc" parent="1092" relname="span"/>
<group id="1094" type="span" parent="1093" relname="joint"/>
<group id="1095" type="span" parent="1093" relname="joint"/>
<group id="1096" type="span" parent="1097" relname="preparation"/>
<group id="1097" type="span" parent="1095" relname="span"/>
<group id="1098" type="span" parent="1100" relname="preparation"/>
<group id="1099" type="span" parent="98" relname="elaboration"/>
<group id="1100" type="multinuc" parent="1097" relname="span"/>
<group id="1101" type="span" parent="1100" relname="joint"/>
<group id="1102" type="multinuc" parent="1101" relname="span"/>
<group id="1103" type="multinuc" parent="1102" relname="joint"/>
<group id="1104" type="span" parent="1103" relname="joint"/>
<group id="1105" type="multinuc" parent="1103" relname="joint"/>
<group id="1106" type="span" parent="1105" relname="sequence"/>
<group id="1107" type="span" parent="1106" relname="span"/>
<group id="1108" type="multinuc" parent="1105" relname="sequence"/>
<group id="1109" type="span" parent="1108" relname="joint"/>
<group id="1110" type="span" parent="1109" relname="span"/>
<group id="1111" type="span" parent="1110" relname="elaboration"/>
<group id="1112" type="span" parent="111" relname="elaboration"/>
<group id="1113" type="multinuc" parent="1108" relname="joint"/>
<group id="1114" type="span" parent="1113" relname="joint"/>
<group id="1115" type="span" parent="114" relname="elaboration"/>
<group id="1116" type="span" parent="115" relname="elaboration"/>
<group id="1117" type="span" parent="116" relname="elaboration"/>
<group id="1118" type="span" parent="117" relname="elaboration"/>
<group id="1119" type="span" parent="1113" relname="joint"/>
<group id="1120" type="span" parent="1121" relname="preparation"/>
<group id="1121" type="multinuc" parent="1119" relname="span"/>
<group id="1122" type="span" parent="1121" relname="joint"/>
<group id="1123" type="span" parent="1124" relname="preparation"/>
<group id="1124" type="multinuc" parent="1122" relname="span"/>
<group id="1125" type="span" parent="1124" relname="joint"/>
<group id="1126" type="multinuc" parent="1125" relname="span"/>
<group id="1127" type="multinuc" parent="1126" relname="joint"/>
<group id="1128" type="multinuc" parent="1127" relname="joint"/>
<group id="1129" type="multinuc" parent="1128" relname="joint"/>
<group id="1130" type="span" parent="1129" relname="joint"/>
<group id="1131" type="multinuc" parent="1129" relname="joint"/>
<group id="1132" type="span" parent="1131" relname="joint"/>
<group id="1133" type="span" parent="1132" relname="span"/>
<group id="1134" type="span" parent="133" relname="elaboration"/>
	</body>
</rst>
